MedTrace Logo

Responses to COVID-19 Vaccination in Patients With Cancer

NCT04745377 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 332

Last updated 2022-08-17

No results posted yet for this study

Summary

This is an observational study that will prospectively record and monitor responses and clinical outcomes of patients with cancer after covid-19 vaccination, including measurements of antibody titers in serum and also record potential factors that affect immunity, such as type and stage of cancer, type and time of systemic therapy in relation to covid-19 vaccination.

Conditions

Interventions

DIAGNOSTIC_TEST

IgG neutralising antibody titers to S1 and S2 proteins of SARS-COV-2 virus

IgG neutralising antibody titers to S1 and S2 proteins of SARS-COV-2 virus

Sponsors & Collaborators

  • Hellenic Cooperative Oncology Group

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-12
Primary Completion
2021-10-14
Completion
2022-05-20

Countries

  • Greece

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04745377 on ClinicalTrials.gov